Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
11.01
0.11 (1.01%)
At close: Aug 15, 2025, 3:45 PM

Intellia Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
189.18M 226.75M 523.51M 123.41M
Short-Term Investments
412.33M 685.48M 669.12M 625.28M
Long-Term Investments
44.26M 154.51M 142.32M 425.05M
Other Long-Term Assets
260.21M n/a n/a n/a
Receivables
8.52M 36.46M 3.77M 2.03M
Inventory
n/a n/a -69.34M n/a
Other Current Assets
29.83M 49.65M 89.75M n/a
Total Current Assets
639.86M 998.33M 1.22B 769.3M
Property-Plant & Equipment
246.67M 148.13M 161M 100.11M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
551.15M 302.65M 303.32M 525.16M
Total Assets
1.19B 1.3B 1.52B 1.29B
Account Payables
14.59M 7.45M 5.15M 9.65M
Deferred Revenue
20.66M 22.14M 43.84M 63.76M
Short-Term Debt
n/a n/a 16.68M 9.11M
Other Current Liabilities
55.35M 6.89M 22.41M 13.84M
Total Current Liabilities
110.85M 115.21M 126.55M 125.83M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 38.85M 24.03M 63.48M
Total Long-Term Liabilities
208.21M 135.6M 157.98M 128.39M
Total Liabilities
319.06M 250.81M 284.53M 254.22M
Total Debt
210.2M 115.35M 130.7M 74.02M
Common Stock
10K 9K 9K 7K
Retained Earnings
-2.18B -1.66B -1.18B -703M
Comprehensive Income
605K -2.26M -7.46M -2.63M
Shareholders Equity
871.96M 1.05B 1.24B 1.04B
Total Investments
456.6M 839.99M 811.44M 1.05B